Katzenell Dimant represents SteadyMed Ltd. in its Nasdaq IPO: on March 25, 2015, the company announced the closing of its initial public offering of 4,700,000 ordinary shares at a price to the public of $8.50 per share, resulting in gross proceeds of approximately $40,000,000 before underwriting discounts and commissions.